A new method for adjusting CYP1A2 metabolic ratios from uncontrolled dietary caffeine intake

被引：0
|
作者：
Jetter, A. [1 ]
Urry, E. [2 ]
Landolt, H. P. [2 ]
机构：
[1] Univ Hosp Zurich, Dept Clin Pharmacol & Toxicol, Zurich, Switzerland
[2] Univ Zurich, Inst Pharmacol & Toxicol, Human Sleep Psychopharmacol Lab, Zurich, Switzerland
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2017年 / 390卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P240
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [31] A formation of guanoxabenz from guanabenz in human liver - A new metabolic marker for CYP1A2
    Clement, B
    Demesmaeker, M
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (11) : 1266 - 1271
  • [32] The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population
    Chen, XP
    Wang, LQ
    Zhi, LT
    Zhou, GQ
    Wang, HJ
    Zhang, XM
    Hao, BT
    Zhu, YP
    Cheng, Z
    He, FC
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (03) : 249 - 259
  • [33] Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics
    Perera, Vidya
    Gross, Annette S.
    Xu, Hongmei
    McLachlan, Andrew J.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, 63 (09) : 1161 - 1168
  • [34] Metabolic Activation of Perampanel Mediated by CYP1A2
    Ding, Zifang
    Wang, Xu
    Zhang, Ning
    Sun, Chen
    Zhao, Guode
    Peng, Ying
    Zheng, Jiang
    CHEMICAL RESEARCH IN TOXICOLOGY, 2022, 35 (03) : 490 - 498
  • [35] The paraxanthine caffeine ratio in saliva as a marker of CYP1A2 activity
    Rostami-Hodjegan, A
    Forsyth, J
    Grünewald, RA
    Lennard, MS
    Sagar, HJ
    Tucker, GT
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (05) : 587 - 588
  • [36] Assays for CYP1A2 by testing in vivo metabolism of caffeine in humans
    Tang, BK
    Kalow, W
    CYTOCHROME P450, PT B, 1996, 272 : 124 - 131
  • [37] Caffeine, CYP1A2 genotype, and sports performance: is timing important?
    Pickering, Craig
    IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 (01) : 349 - 350
  • [38] HPLC ASSAY OF CAFFEINE AND PARAXANTHINE FOR CYP1A2 PHENOTYPE ASSESSMENT
    Rehman, S.
    Razzaq, A.
    Kamal, S.
    Bibi, I.
    Kiran, S.
    Nouren, S.
    Ayub, C. M.
    Hamid, M.
    OXIDATION COMMUNICATIONS, 2016, 39 (03): : 2344 - 2353
  • [39] Caffeine, CYP1A2 genotype, and sports performance: is timing important?
    Craig Pickering
    Irish Journal of Medical Science (1971 -), 2019, 188 : 349 - 350
  • [40] In vivo evaluation of CYP1A2 CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios
    Begas, E.
    Kouvaras, E.
    Tsakalof, A.
    Papakosta, S.
    Asprodini, E. K.
    BIOMEDICAL CHROMATOGRAPHY, 2007, 21 (02) : 190 - 200
12345